DK0661975T3 - Transdermal behandling af nældefeber ved anvendelse af optisk rent (+)-cetirizin - Google Patents

Transdermal behandling af nældefeber ved anvendelse af optisk rent (+)-cetirizin

Info

Publication number
DK0661975T3
DK0661975T3 DK94910260T DK94910260T DK0661975T3 DK 0661975 T3 DK0661975 T3 DK 0661975T3 DK 94910260 T DK94910260 T DK 94910260T DK 94910260 T DK94910260 T DK 94910260T DK 0661975 T3 DK0661975 T3 DK 0661975T3
Authority
DK
Denmark
Prior art keywords
cetirizine
optically pure
treatment
hives
useful
Prior art date
Application number
DK94910260T
Other languages
Danish (da)
English (en)
Inventor
Nancy M Gray
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DK0661975T3 publication Critical patent/DK0661975T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94910260T 1992-09-24 1993-09-22 Transdermal behandling af nældefeber ved anvendelse af optisk rent (+)-cetirizin DK0661975T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95091092A 1992-09-24 1992-09-24
PCT/US1993/008999 WO1994006430A1 (fr) 1992-09-24 1993-09-22 Procedes et compositions de traitement de troubles allergiques a l'aide de cetirizine (+) optiquement pure

Publications (1)

Publication Number Publication Date
DK0661975T3 true DK0661975T3 (da) 1999-09-27

Family

ID=25491013

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94910260T DK0661975T3 (da) 1992-09-24 1993-09-22 Transdermal behandling af nældefeber ved anvendelse af optisk rent (+)-cetirizin

Country Status (11)

Country Link
US (1) US5627183A (fr)
EP (2) EP0885611A3 (fr)
JP (1) JPH08501562A (fr)
AT (1) ATE177636T1 (fr)
AU (1) AU5136193A (fr)
CA (1) CA2145413A1 (fr)
DE (1) DE69324025T2 (fr)
DK (1) DK0661975T3 (fr)
ES (1) ES2128556T3 (fr)
GR (1) GR3029927T3 (fr)
WO (1) WO1994006430A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
AU4932093A (en) * 1992-09-24 1994-04-12 Sepracor, Inc. Compositions for treating allergic disorders using (-) cetirizine
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
EP0811374A1 (fr) * 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine
IN188720B (fr) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
US6432961B1 (en) * 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US6762347B1 (en) * 1999-07-12 2004-07-13 James Giovannoni NOR gene compositions and methods for use thereof
HU228233B1 (en) * 1999-12-28 2013-02-28 Teikoku Seiyaku Co Antipruritic agents for external use
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
US6596686B2 (en) 2001-03-12 2003-07-22 International Flavors & Fragrances Inc. Use of dihydropyrans as fragrance Material
WO2004069338A1 (fr) * 2003-01-31 2004-08-19 Schering Corporation Utilisation de combinaisons d'antagonistes du recepteur h1 et h3 de l'histamine pour la preparation d'un medicament destine au traitement d'etats cutanes et oculaires d'origine allergique
GB2403655A (en) * 2003-07-11 2005-01-12 Cipla Ltd Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
WO2005077371A1 (fr) * 2004-02-12 2005-08-25 Ucb Farchim Sa Utilisation de la levocetirizine pour la preparation d'un medicament
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US11253513B2 (en) 2019-10-07 2022-02-22 Jdp Therapeutics Llc Dosing regimen for injectable cetirizine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
AU4932093A (en) * 1992-09-24 1994-04-12 Sepracor, Inc. Compositions for treating allergic disorders using (-) cetirizine
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine

Also Published As

Publication number Publication date
EP0661975B1 (fr) 1999-03-17
DE69324025T2 (de) 1999-07-15
ES2128556T3 (es) 1999-05-16
GR3029927T3 (en) 1999-07-30
EP0885611A3 (fr) 1999-01-07
ATE177636T1 (de) 1999-04-15
EP0885611A2 (fr) 1998-12-23
EP0661975A1 (fr) 1995-07-12
AU5136193A (en) 1994-04-12
JPH08501562A (ja) 1996-02-20
CA2145413A1 (fr) 1994-03-31
WO1994006430A1 (fr) 1994-03-31
DE69324025D1 (de) 1999-04-22
US5627183A (en) 1997-05-06

Similar Documents

Publication Publication Date Title
DK0663828T3 (da) Behandling af allergisk rhinitis og asthma ved anvendelse af (-)cetirizin
DK0661975T3 (da) Transdermal behandling af nældefeber ved anvendelse af optisk rent (+)-cetirizin
CA2161256A1 (fr) Methodes et compositions pour le traitement des troubles gastriques grace a du (-)-pantoprazole optiquement pur
BG103725A (en) Nicotineamide derivatives
RU95113454A (ru) Катехольные диэфиры как селективные ингибиторы фдэiv, фармацевтическая композиция, способы лечения
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
FI935555A0 (fi) Nya sulfonamider
NO900855L (no) Substituerte pyrroler.
DE69424362D1 (de) Verwendung von Histamin-gamma-globulin zur Herstellung eines immunomodulierenden und antiinflammatorischen Agens
FI904035A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 4-substituoituja 17 -(syklopropyyliamino)androst-5-eenijohdannaisia, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
ZA882717B (en) 17beta-(cyclopropylamino)-androst-5-eb-3beta-ol and related compounds useful as c17-20 lyase inhibitors
DE69030632T2 (de) Substituierte Chinolincarboxylsäure
NO20052560L (no) Krystallinske fumaratsalter av N-[1-azabicyclo (2.2.2) okt-3yl] furo (2,3-C) pyridinyl-5-karboksamid samt sammensetninger og preparater derav.
ATE101147T1 (de) Pharmazeutisch verwendbare polymorphe modifikation von buspiron.
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
NO20001343L (no) FremgangsmÕter og sammensetninger for behandling av pulmonære forstyrrelser ved anvendelse av optisk ren (S)-salmeterol
ES2096368T3 (es) Quinolil-dihidropiridinas condensadas, procedimiento para su preparacion y su uso en medicamentos para el tratamiento de enfermedades cardiocirculatorias.
DK1124556T3 (da) Anvendelse af optisk rent (R)-tofisopam til behandling og forebyggelse af angstsygdomme
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
IS3961A (is) Indolafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
FR2653999B1 (fr)
FI880385A0 (fi) Substituerade 3-fenyl-7h-tiazolo /3,2-b//1,2,4/-triazin-7-oner, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter.
DE502004011353D1 (de) Verfahren zur Destillation eines Gemisches isomerer Diisocyanatodiphenylmethane
FI851617A0 (fi) Triazolopyrimidinderivat.
MX9710257A (es) Azepanes novedosos y sus homologos de anillo para terapia y profilaxis de enfermedades mediadas por proteina cinasa.